Patients

Being treated in a Comprehensive Cancer Center

Find out more about us

Healthcare professionals

Unicancer care and research

Your page

Find a Center

Retrouvez les Centres de lutte contre le cancer sur l'ensemble du territoire

2016

Results of a phase II trial of abiraterone acetate plus prednisone in patients with a molecular apocrine HER2-negative locally advanced or metastatic breast cancer (UCBG 2012-1)

Congress : EBCC 10

Authors : T. Grellety, H. Bonnefoi, O. Tredan, F. Dalenc, P. Cottu, A. Mailliez, M. Saghatchian, S. Abadie-Lacourtoisie, T. L'Haridon, F. Del Piano, I. Desmoulins, F. Coussy, J. Dauba, J. Grenier, M. Mousseau, G. MacGrogan, C. Orsini, M. Pulido and A. Goncalves.

Experts group or program : French Breast Cancer Intergroup (UCBG)

 

En savoir plus